[Analysis of 33C4 monoclonal antibody associated with aggregation of human B lymphocytes]

T Ayabe1, M Katagiri

  • 12nd Dept. of Pathology, Asahikawa Medical College.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|November 1, 1989
PubMed

Insights

Researchers identified a novel molecule, 33C4, that specifically induces aggregation in B cells, offering new insights into immune cell adhesion mechanisms and potential therapeutic targets.

Area of Science:

  • Immunology
  • Cell Biology

Context:

  • Immune responses rely on immunocyte interactions mediated by cell adhesion.
  • Homotypic adhesion mechanisms in B cells remain poorly understood.

Purpose:

  • To identify molecules involved in B cell adhesion and aggregation.
  • To investigate the specific role of novel molecules in B cell interactions.

Summary:

  • Monoclonal antibody (mAb) 33C4 was generated against human B lymphoblastoid cells.
  • mAb 33C4 specifically induced aggregation in B cells, but not T cells.
  • Structural analysis revealed 33C4 as a unique 45 kDa monomer, distinct from known adhesion molecules.

Impact:

  • Identifies a novel molecule, 33C4, potentially crucial for B cell aggregation.
  • Provides a new tool for studying B cell homotypic adhesion.
  • Suggests 33C4 as a distinct B cell adhesion molecule, separate from LFA-1, ICAM-1, and LFA-3.